SCHEMBL10110702

SCHEMBL10110702

c1ccc(-c2ccc(-c3ccc(N(c4cccc(-c5ccc6oc7ccccc7c6c5)c4)c4cccc(-c5cccc6c5oc5ccccc56)c4)cc3)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.51
GGPS1 O95749 1/20 0.42
PLA2G2A P14555 4/20 0.40
PLA2G4A P47712 4/20 0.40
PRKDC P78527 5/20 0.39
PTGES2 Q9H7Z7 1/20 0.39
PLA2G10 O15496 1/20 0.38
PIM1 P11309 1/20 0.36
CSNK2A2 P19784 1/20 0.36
CSNK2B P67870 1/20 0.36
PIM3 Q86V86 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17153426 1.00 ALOX5 (0.51) ALOX5GGPS1PLA2G2APLA2G4APRKDC
SCHEMBL17153473 0.99 ALOX5 (0.52) ALOX5GGPS1PLA2G2APLA2G4APRKDC
SCHEMBL17153522 0.99 ALOX5 (0.52) ALOX5GGPS1PLA2G2APLA2G4APRKDC
SCHEMBL17153521 0.99 ALOX5 (0.52) ALOX5GGPS1PLA2G2APLA2G4APRKDC
SCHEMBL17153612 0.98 ALOX5 (0.48) ALOX5GGPS1PLA2G2APLA2G4APRKDC
SCHEMBL17153441 0.98 ALOX5 (0.51) ALOX5GGPS1PLA2G2APLA2G4APRKDC
SCHEMBL17153609 0.98 ALOX5 (0.48) ALOX5GGPS1PLA2G2APLA2G4APRKDC
SCHEMBL18383357 0.98 ALOX5 (0.51) ALOX5GGPS1PLA2G2APLA2G4APRKDC
SCHEMBL25621719 0.98 ALOX5 (0.48) ALOX5GGPS1PLA2G2APLA2G4APRKDC
SCHEMBL17153429 0.98 ALOX5 (0.48) ALOX5GGPS1PLA2G2APLA2G4APRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140061630-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-03-06 US disclosed
US-20140061630-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-03-06 US disclosed
US-20120161119-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-28 US disclosed
US-20120161119-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120161119-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE TYR, TERF2, SAT1 ALOX5 3505/4885GGPS1 2974/4885PLA2G2A 4230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.